about
Pyruvate kinase M2 activation may protect against the progression of diabetic glomerular pathology and mitochondrial dysfunction.Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383-390.Circulating miRNA Profiles Associated With Hyperglycemia in Patients With Type 1 Diabetes Mellitus.A signature of circulating inflammatory proteins and development of end-stage renal disease in diabetesCharacterization of Glycolytic Enzymes and Pyruvate Kinase M2 in Type 1 and 2 Diabetic Nephropathy
P50
description
researcher
@en
name
Monika A Niewczas
@en
type
label
Monika A Niewczas
@en
prefLabel
Monika A Niewczas
@en
P31
P496
0000-0003-2371-595X